SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending as investors prepare for a critical FDA advisory committee meeting on July 29 regarding deramiocel, a treatment for Duchenne muscular dystrophy. The community is focused on the potential for a dual-label approval for both skeletal and cardiac function, while actively debating the impact of recent briefing documentation and high short interest on the stock's near-term volatility.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. It provides customers with access to the company’s quantum computing systems via the cloud in the form of quantum computing as a service. It offers professional services such as customer assistance in identifying and implementing quantum-computing applications. The company was founded on January 25, 2022 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

D-Wave Quantum is trending as investors react to a recent grant from the National Science Foundation, which bolsters the company's long-term fault-tolerant computing goals and strategic standing. While some community members remain optimistic about future contract potential and national security positioning, others are voicing concerns over recent insider share sales and the volatility typical of this high-growth sector.

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

Rigetti Computing is trending as investors react to new executive orders designed to accelerate national quantum technology leadership and secure data migration. While some community members view this as a potential long-term catalyst for growth, others remain cautious, actively debating the stock's high cash burn, recent insider selling, and concerns that these government-linked announcements may lead to volatility rather than sustained upside.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. is trending as investors weigh its potential as a key player in Western rare earth supply chains against volatility in the critical minerals sector and ongoing discussions regarding its Tanbreez project's development timeline. Community discourse is highly polarized, with intense debate centered on management transparency, the impact of recent dilution, and speculation surrounding upcoming tender opportunities for major rare earth deposits.

Omeros Corp. operates as a biopharmaceutical company, which engages in the research, discovery, development, and commercialization of small-molecule and protein therapeutics targeting immunologic diseases. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros Corp is trending as investors react to a negative opinion from the CHMP regarding the marketing authorization of Yartemlea in Europe, prompting the company to initiate an appeal through an Ad Hoc Expert Group. While community members are expressing significant frustration over regulatory hurdles and management's communication, many remain bullish on the company's US outlook, citing upcoming J-code implementation and a potential $100 million milestone payment as primary catalysts.

Forte Biosciences, Inc. is a biopharmaceutical company, which engages in the provision of dermatology products and services. Its lead product includes FB-401, which is a live biotherapeutic for the treatment of inflammatory skin disease, including pediatric and adult patients with atopic dermatitis. The company was founded by Paul A. Wagner on May 3, 2017 and is headquartered in Dallas, TX.

Forte Biosciences Inc

Forte Biosciences is rallying following the announcement of a $53 million private placement that has significantly bolstered its balance sheet. While investors are debating the long-term impact of potential dilution, the community is closely watching for momentum to continue as the stock remains a high-interest play in the biotech sector.

Litecoin is a decentralized, peer-to-peer digital currency designed to enable instant, near-zero cost payments to individuals and merchants worldwide. As an open-source global payment network that functions independently of central banks or intermediaries, its main value proposition lies in providing a scarce digital asset with a fixed maximum supply of 84 million tokens.  The network operates using a Proof of Work mechanism where computers solve complex puzzles to confirm transactions and secure the blockchain. It is distinguished by a block generation time of 2.5 minutes, which allows for faster transaction confirmations and a higher total throughput than earlier protocols. Key technical features include the Scrypt hashing algorithm, which promotes wider network participation, and MimbleWimble Extension Blocks, which improve user privacy by allowing transaction details to be hidden.  The LTC token is used for settling global payments, executing microtransactions through smaller units called litoshis, and diversifying digital portfolios with a highly liquid asset. New tokens are issued to miners as rewards for verifying blocks, though these rewards undergo a halving event approximately every four years to strictly control inflation. This process ensures the ledger maintains immutability, meaning records cannot be changed once they are saved to the global network.  Created by former Google engineer Charlie Lee, the project is supported by the Litecoin Foundation, a non-profit organization dedicated to ecosystem adoption. Unlike many venture-backed projects, it is maintained by a decentralized community of independent developers and a global network of miners. The project has seen recent institutional adoption, with entities like Lite Strategy and Luxxfolio Holdings adding significant amounts of LTC to their corporate treasuries as of late 2025.

Litecoin

Litecoin is experiencing heightened activity as traders debate whether it is forming a major macro bottom or faces further downside, with the community closely tracking its interaction with key price levels and institutional custody developments. Speculation remains intense regarding whether current technical structures and market indicators signal an imminent breakout or continued consolidation, fueled by ongoing debates over its long-term utility.

Legend Biotech Corp. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, manufacturing, and commercialization of novel therapies for oncology and other indications. The firm develops advanced cell therapies across a diverse array of technology platforms, including autologous and allogeneic chimeric antigen receptor T-cell, gamma-delta T cell and natural killer cell-based immunotherapy. It operates through the following geographical segments: United States of America, China, and Other. The company was founded in 2014 and is headquartered in Somerset, NJ.

Legend Biotech Corp - ADR

Legend Biotech

Legend Biotech is facing significant downward pressure following leadership changes and investor concerns over competitive threats from new therapies in the multiple myeloma space. While community sentiment remains divided, many investors are focused on the company's strong sales growth and potential for a strategic acquisition to unlock value.

ProShares Trust II - ProShares UltraShort Bloomberg Crude Oil -2x Shares

ProShares UltraShort Bloomberg Crude Oil

The community is actively debating the future of crude oil prices amid geopolitical tension, with many traders using SCO as a tactical vehicle to hedge against ongoing supply disruptions in the Strait of Hormuz. Sentiment remains highly divided between those betting on a swift diplomatic resolution that would trigger a rapid decline in oil prices and others concerned that persistent supply constraints and futures market decay will continue to pressure the fund's performance.

Anthropic

Anthropic is currently in the spotlight due to high-stakes regulatory scrutiny regarding export controls and national security concerns, which have impacted access to its latest models. Amid this, the community is actively debating the company's aggressive infrastructure partnerships, valuation, and the broader race toward a highly anticipated IPO.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Casey's General Stores (CASY) Boasts Earnings & Price Momentum: Should You Buy?

The Zacks Focus List offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.

Here's Why Casey's General Stores (CASY) is a Strong Growth Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Why Is Casey's (CASY) Down 7.9% Since Last Earnings Report?

Casey's (CASY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Why Casey's General Stores (CASY) is a Top Stock for the Long-Term

Is Burlington Stores (BURL) Stock Outpacing Its Retail-Wholesale Peers This Year?

Here is how Burlington Stores (BURL) and Casey's General Stores (CASY) have performed compared to their sector so far this year.

Top 5 Non-AI S&P 500 Stock Picks for 2H 2026 That Have Surged in 1H

ADM, CASY, DVA, CVS and BEN top a list of five non-AI S&P 500 stocks that surged more than 30% in 1H 2026 and still show momentum for 2H.

The Zacks Analyst Blog Highlights Five Below, Casey's General Stores, Ross Stores and Dollar Tree

Five Below, Casey's, Ross Stores and Dollar Tree stand out as easing gas prices and value-focused shopping trends support select retail stocks.

4 Must-Buy Retail Stocks as Lower Gas Prices Boost Consumer Confidence

Lower gas prices lift confidence in June, putting Five Below, Casey's, Ross Stores and Dollar Tree in focus as shoppers stay selective.

If You Invested $1000 in Casey's General Stores a Decade Ago, This is How Much It'd Be Worth Now

Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.

What's Driving Casey's Strong Inside Same-Store Sales Growth?

CASY drives strong inside sales with menu innovation, value pricing and growth across food, beverages and merchandise.

This account has been verified as an official CASY representative.

Verified Account

Casey's General Stores, Inc. engages in the provision of management and operation of convenience stores and gasoline stations. It provides self-service gasoline, a wide selection of grocery items, and an array of freshly prepared food items. The firm offers food, beverages, tobacco products, health and beauty aids, automotive products, and other non-food items. The company was founded by Donald F. Lamberti in 1968 and is headquartered in Ankeny, IA.

Casey`s General Stores, Inc.

Dow Futures Edge Lower As Wall Street Cautiously Awaits Revised Jobs Data: AAPL, WOLF, ASML, CASY Among Stocks To Watch

Equity

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '26	$6.66	--	--	N/A
Q4 '25	$3.31	$4.37	32.01%	BEAT
Q3 '25	$3.00	$3.49	16.19%	BEAT
Q2 '25	$5.19	$5.53	6.64%	BEAT
Q1 '25	$5.02	$5.77	14.99%	BEAT

Feed

News

Sentiment

Earnings

Fundamentals

Info

CASYCasey`s General Stores, Inc.

Upcoming Earnings: Q1 '26

Historical Earnings

Latest CASY News